Kari Helen Simonsen

Kari Simonsen is a European Patent Attorney with more than 20 years’ Life Sciences/Pharmaceutical sector IPR experience, specializing in the area of Chemistry, Pharmacy and Biotechnology. Kari’s clients belong to the pharmaceutical industry, biotechnology industry, food industry, aquaculture industry and renewables and range from multinational companies to start ups. She was formerly a Senior Examiner at The Norwegian Industrial Property Office (NIPO). Today, Kari assists clients in drafting and handling patent applications and oppositions, freedom-to-operate evaluations, infringement and validity issues and IP strategy.

In 2023, Kari successfully obtained the University degree on Patent Litigation in Europe at the International Center of Intellectual Property Studies, University of Strasbourg (France). Kari is now registered as a representative before the Unified Patent Court (UPC).

In the last 22 years Kari has acquired extensive experience of Infringement and Validity in numerous pharma sector patent litigation cases in Norway by way of assisting the IP lawyers of various clients. The cases include inter alia infringement and/or revocation issues concerning patents related to compounds like paroxetine, citalopram, escitalopram, omeprazole, lansoprazole, atorvastatin, alendronate, bicalutamide, donepezil, irbesartan, oxycodone, sildenafil, formoterol/budesonide, rituximab, apixaban, a Salmonid alphavirus vaccine, and others.